Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Amortization of Deferred Charges (2022 - 2025)

Historic Amortization of Deferred Charges for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $248000.0.

  • Gossamer Bio's Amortization of Deferred Charges rose 598.29% to $248000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $972000.0, marking a year-over-year decrease of 1591.7%. This contributed to the annual value of $1.1 million for FY2024, which is 1778.96% down from last year.
  • As of Q3 2025, Gossamer Bio's Amortization of Deferred Charges stood at $248000.0, which was up 598.29% from $245000.0 recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Amortization of Deferred Charges registered a high of $352000.0 during Q1 2023, and its lowest value of $234000.0 during Q3 2024.
  • Moreover, its 4-year median value for Amortization of Deferred Charges was $293000.0 (2024), whereas its average is $286933.3.
  • As far as peak fluctuations go, Gossamer Bio's Amortization of Deferred Charges surged by 2054.79% in 2023, and later crashed by 2755.42% in 2024.
  • Over the past 4 years, Gossamer Bio's Amortization of Deferred Charges (Quarter) stood at $270000.0 in 2022, then increased by 14.07% to $308000.0 in 2023, then dropped by 22.73% to $238000.0 in 2024, then rose by 4.2% to $248000.0 in 2025.
  • Its last three reported values are $248000.0 in Q3 2025, $245000.0 for Q2 2025, and $241000.0 during Q1 2025.